1 / 4

Atopic Dermatitis Treatment Market Research and Forecast 2020-2026

The global atopic dermatitis treatment market is anticipated to showcase considerable growth during the forecast period (2020-2026). The new product launches with rising FDA approvals are a factor contributing to the growth of the market. Atopic dermatitis (a most common and severe form of eczema) is an inflammatory skin condition that affects nearly 30% of the US population, mostly children and adolescents.

shriram01
Télécharger la présentation

Atopic Dermatitis Treatment Market Research and Forecast 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Atopic Dermatitis Treatment Market Size, Share, Trends, Analysis and Forecast 2020-2026 Request https://www.omrglobal.com/request-sample/atopic-dermatitis-treatment-market a free sample of our report on Atopic Dermatitis Treatment Market: ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

  2. The global atopic dermatitis treatment market is anticipated to showcase considerable growth during the forecast period (2020-2026). The new product launches with rising FDA approvals are a factor contributing to the growth of the market. Atopic dermatitis (a most common and severe form of eczema) is an inflammatory skin condition that affects nearly 30% of the US population, mostly children and adolescents. A https://www.omrglobal.com/industry-reports/atopic-dermatitis-treatment-market full report of Atopic Dermatitis Treatment Market is available at: Pfizer, Inc., Mylan N.V., Bausch Health Companies Inc., Bayer HealthCare AG, Encore Dermatology, Inc., AbbVie Inc., Allergan PLC, GlaxoSmithKline PLC, and so on are the key players operating in the global atopic dermatitis treatment market. These players are actively involved in adopting different growth strategies such as mergers and acquisitions, partnerships, collaboration, and strategic agreements among others to remain competitive in the market place. New product launches and investment in the R&D is the key strategy adopted by the players of the global market to sustain their marketplace. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/atopic-dermatitis-treatment-market In June 2020, Eli Lily and Company had received positive top-line results from the North American (breeze-ad5) phase 3 study of oral selective JAK inhibitor baricitinib in patients with moderate to severe atopic dermatitis. In October 2019, Dermira, Inc. (fully owned subsidiary of Eli Lily and Company), a biopharmaceutical company had received US FDA approval for Fast Track designation for lebrikizumab, its novel, investigational treatment being evaluated for patients with moderate-to-severe atopic dermatitis. Lebrikizumab is currently being evaluated in two Phase 3 studies, ADvocate 1 and ADvocate 2, to confirm its safety and efficacy in adolescent and adult patients, ages 12 years and older, with moderate-to-severe atopic dermatitis. In March 2018, Sanofi SA received FDA approval for Dupixent (Dupilumab), the first biologic drug approved for patients with moderate-to-severe atopic dermatitis. Global Atopic Dermatitis Treatment Market Segmentation By Drug Class Corticosteroids PDE-4 Inhibitor Emollients Calcineurin Inhibitors Antibiotics Others

  3. By Route of Administration Oral Topical Injectable For more customized data, request for report customization @ https://www.omrglobal.com/report- customization/atopic-dermatitis-treatment-market Global Atopic Dermatitis Treatment Market – Segment by Region North America United States Canada Europe Germany United Kingdom France Spain Italy Rest of Europe Asia-Pacific China Japan India Rest of Asia-Pacific Rest of the World Middle East & Africa Latin America

  4. Company Profiles AbbVie, Inc. Allergan PLC Bausch Health Companies, Inc. Bayer HealthCare AG Beiersdorf, Inc. Encore Dermatology, Inc. Eli Lily and Co. Galderma laboratories, L.P. GlaxoSmithKline PLC LEO Pharma A/S Mylan N.V. Novartis International AG Pfizer, Inc. Regenron Pharmaceutical, Inc. Sanofi S.A. About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803-040-404

More Related